Evidence map›Paper›PMID 33053828›Full record

SynthesisNutrients2020

Application of Citicoline in Neurological Disorders: A Systematic Review.

Patryk Jasielski, Faustyna Piędel, Mikołaj Piwek, Agata Rocka, Véronique Petit, Konrad Rejdak

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 4 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 4 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Neuroprotection beyond intraocular pressure: game changer or quiet addiction.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Real-life management of patients with mild cognitive impairment: an Italian survey.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Patryk JasielskiDepartment of Neurology, Medical University of Lublin, 20-059 Lublin, Poland.
Faustyna PiędelDepartment of Neurology, Medical University of Lublin, 20-059 Lublin, Poland.
Mikołaj PiwekDepartment of Neurology, Medical University of Lublin, 20-059 Lublin, Poland.
Agata RockaDepartment of Neurology, Medical University of Lublin, 20-059 Lublin, Poland.
Véronique PetitDepartment of Neurology, Medical University of Lublin, 20-059 Lublin, Poland.
Konrad RejdakDepartment of Neurology, Medical University of Lublin, 20-059 Lublin, Poland.
Medical University of Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Citicoline is a chemical compound involved in the synthesis of cell membranes. It also has other, not yet explained functions. Research on the use of citicoline is conducted in neurology, ophthalmology, and psychiatry. Citicoline is widely available as a dietary supplement. It is often used to enhance cognitive functions. In our article, accessible databases were searched for articles regarding citicoline use in neurological diseases. This article has a systemic review form. After rejecting non-eligible reports, 47 remaining articles were reviewed. The review found that citicoline has been proven to be a useful compound in preventing dementia progression. It also enhances cognitive functions among healthy individuals and improves prognosis after stroke. In an animal model of nerve damage and neuropathy, citicoline stimulated regeneration and lessened pain. Among patients who underwent brain trauma, citicoline has an unclear clinical effect. Citicoline has a wide range of effects and could be an essential substance in the treatment of many neurological diseases. Its positive impact on learning and cognitive functions among the healthy population is also worth noting.

Indexed as

AnimalsBrain Injuries, TraumaticCognitionCytidine Diphosphate CholineDementiaDisease Models, AnimalHumansMeta-Analysis as TopicNervous System DiseasesNeuralgiaNeurotransmitter AgentsPeripheral Nervous SystemStrokeCytidine Diphosphate CholineNeurotransmitter Agentsciticolineneurologysupplementationtreatment

Identifiers

PMID33053828
PMCPMC7601330
OpenAlexW3092414921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.